Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andrographolide to reduce hospitalization in mild or asymptomatic COVID-19
TCTR20210514003Phase 3Not yet recruiting
- Sponsor
- Department of Thai Traditional and Alternative Medicine
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of andrographolide in coronavirus disease 2019 (COVID-19), sponsored by Department of Thai Traditional and Alternative Medicine. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
andrographolide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210514003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210514003.